On-Demand Catalog

All sessions average between 60 and 90 minutes.

Restarting Clinical Trials in the Wake of COVID-19
COVID-19 and Tobacco and Nicotine Products: Enforcement Disruptions, Industry Impact, and Possible Links Between Product Usage and Contracting or Worsening the Illness
What Does Current Cannabis Research Tell Us and What Are Future Prospects for Research Access?
Animal Drug Compounding: FDA’s New Guidance and Impacts on Industry
COVID-19 and Beyond: Development and Implementation of Recovery Action Plans for Medical Product Manufacturers
The Long-Awaited Biologics Transition Date Has Come: What Now?
FDA’s Recent COVID-19 Guidances Facilitating Expanded Access to Certain Medical Products
COVID-19 and Beyond: Crisis Preparation, Management, and Recovery in the Food and Dietary Supplement Industries
What are FDA’s Tools for Responding to Public Health Emergencies Such as the Coronavirus (COVID-19)?
FDA-Related Congressional Committees: Jurisdiction, Focus, and Roles

Filter Results